The epidemiology of excess mortality in people with mental illness

Canadian Journal of Psychiatry

Volumn 55, Issue 12, 2010, Pages 752-760

  Lawrence, David ^a   Kisely, Stephen ^b,c   Pais, Joanne ^b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cause of death; Health status; Mental health; Mortality

Indexed keywords

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DEVELOPED COUNTRY; HUMAN; LIFE EXPECTANCY; MENTAL DISEASE; MORTALITY; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 78650370592     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005501202     Document Type: Review

References (107)

1. Farr W. On the mortality of lunatics. J Stat Soc Lond. 1841;4:17-33.
2. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173:11-53.
3. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205-228. (Pubitemid 27117683)
4. Lawrence D, Holman CDJ, Jablensky AV, et al. Increasing rates of suicide in Western Australian psychiatric patients: a record linkage study. Acta Psychiatr Scand. 2001;104:443-451. (Pubitemid 33151431)
5. Lawrence D, Jablensky AV, Holman CDJ, et al. Mortality in Western Australian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol. 2000;35:341-347.
6. Laursen TM, Munk-Olsen T, Nordentoft M, et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 2007;68:899-907. (Pubitemid 47015490)
7. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3:A42.
8. Dembling BP, Chen DT, Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50:1036-1042. (Pubitemid 29365365)
9. Hannerz H, Borgå P, Borritz M. Life expectancies for individuals with psychiatric diagnoses. Public Health. 2001;115:328-337. (Pubitemid 32898841)
10. Räsänen S, Hakko H, Viilo K, et al. Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol. 2003;38:297-304. (Pubitemid 37160798)
11. Hiroeh U, Kapur N, Webb R, et al. Deaths from natural causes in people with mental illness: a cohort study. J Psychosom Res. 2008;64:275-283. (Pubitemid 351248873)
12. Amaddeo F, Bisoffi G, Bonizzato P, et al. Mortality among patients with psychiatric illness. A ten-year case register study in an area with a community-based system of care. Br J Psychiatry. 1995;166:783-788.
13. Kisely S, Smith M, Lawrence D, et al. Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatry. 2005;187:552-558.
14. Joukamaa M, Heliövaara M, Knekt P, et al. Mental disorders and cause-specific mortality. Br J Psychiatry. 2001;179:498-502.
15. Bruce ML, Leaf PJ, Rozal GPM, et al. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry. 1994;151:716-721.
16. Hiroeh U, Appleby L, Mortensen PB, et al. Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet. 2001;358:2110-2112.
17. Gau SSF, Cheng ATA. Mental illness and accidental death. Case-control psychological autopsy study. Br J Psychiatry. 2004;185:422-428.
18. Lawrence DM, Holman CDJ, Jablensky AV, et al. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br J Psychiatry. 2003;182:31-36.
19. Gulbinat W, Dupont A, Jablensky A, et al. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiatry Suppl. 1992;(18):75-83.
20. Osborn DPJ, Levy G, Nazareth I, et al. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry. 2007;64:242-249.
21. Lawrence D, Holman CDJ, Jablensky AV, et al. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand. 2000;101:382-388.
22. Kisely S, Sadek J, MacKenzie A, et al. Excess cancer mortality in psychiatric patients. Can J Psychiatry. 2008;53:753-761.
23. Tran E, Rouillon F, Loze JY, et al. Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer. 2009;115:3555-3562.
24. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349-5361.
25. Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374:620-627.
26. Mortensen PB. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr Scand. 1987;75:585-590.
27. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry. 1997;171:502-508.
28. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
29. Auquier P, Lançon C, Rouillon F, et al. Mortality in schizophrenia. Pharmacoepidemiol Drug Saf. 2006;15:873-879.
30. Leucht S, Burkhard T, Henderson J, et al. Physical illness and schizophrenia: a review of the evidence. Cambridge (GB): Cambridge University Press; 2007.
31. Enger C, Weatherby L, Reynolds RF, et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004;192:19-27.
32. Babidge NC, Buhrich N, Butler T. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand. 2001;103:105-110.
33. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6-17.
34. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72:227-236.
35. Zheng D, Macera CA, Croft JB, et al. Major depression and all-cause mortality among white adults in the United States. Ann Epidemiol. 1997;7:213-218.
36. Roberts RE, Kaplan GA, Camacho TC. Psychological distress and mortality: evidence from the Alameda County Study. Soc Sci Med. 1990;31:527-536.
37. Ensinck KTJL, Schuurman AG, van den Akker M, et al. Is there an increased risk of dying after depression? Am J Epidemiol. 2002;156:1043-1048.
38. Parakh K, Thombs BD, Fauerbach JA, et al. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol. 2008;101:602-606.
39. Surtees PG, Wainwright NW, Luben RN, et al. Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. Am J Psychiatry. 2008;165:515-523.
40. Penninx BW, Geerlings SW, Deeg DJ, et al. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry. 1999;56:889-895.
41. von Ammon Cavanaugh S, Furlanetto LM, Creech SD, et al. Medical illness, past depression, and present depression: a predictive triad for in-hospital mortality. Am J Psychiatry. 2001;158:43-48.
42. Lespérance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049-1053.
43. Frasure-Smith N, Lespérance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919-1924. (Pubitemid 30225272)
44. Carney RM, Blumenthal JA, Catellier D, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003;92:1277-1281.
45. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med. 2004;164:289-298.
46. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch Gen Psychiatry. 2006;63:874-880.
47. Parashar S, Rumsfeld JS, Spertus JA, et al. Time course of depression and outcome of myocardial infarction. Arch Intern Med. 2006;166:2035-2043.
48. Glassman AH, Bigger JT Jr, Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry. 2009;66:1022-1029.
49. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry. 2009;166:410-417.
50. Linke SE, Rutledge T, Johnson BD, et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry. 2009;66:499-507.
51. Lespérance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160:1354-1360.
52. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527-1537.
53. Jiang W, Kuchibhatla M, Clary GL, et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J. 2007;154:102-108.
54. Albert NM, Fonarow GC, Abraham WT, et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009;122:366-373.
55. Rathore SS, Wang Y, Druss BG, et al. Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project. Arch Gen Psychiatry. 2008;65:1402-1408.
56. Empana JP, Jouven X, Lemaitre RN, et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006;166:195-200.
57. Whang W, Albert CM, Sears SFS Jr, et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45:1090-1095. (Pubitemid 40432444)
58. Frasure-Smith N, Lespérance F, Habra M, et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation. 2009;120:134-140.
59. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161:1090-1095.
60. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167:60-67. (Pubitemid 46072408)
61. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-1140. (Pubitemid 38857313)
62. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466-1474.
63. Ösby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844-850.
64. Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007;68:917-923.
65. Vythilingam M, Chen J, Bremner JD, et al. Psychotic depression and mortality. Am J Psychiatry. 2003;160:574-576.
66. Ganguli M, Dodge HH, Mulsant BH. Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry. 2002;59:1046-1052.
67. Kasprow WJ, Rosenheck R. Mortality among homeless and nonhomeless mentally ill veterans. J Nerv Ment Dis. 2000;188:141-147.
68. Ösby U, Correia N, Brandt L, et al. Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ. 2000;321:483-484.
69. Capasso RM, Lineberry TW, Bostwick JM, et al. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. Schizophr Res. 2008;98:287-294.
70. Hansen V, Jacobsen BK, Arnesen E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry. 2001;179:438-443.
71. Tsuang MT, Simpson JC. Mortality studies in psychiatry. Should they stop or proceed? Arch Gen Psychiatry. 1985;42:98-103.
72. Sims AC. Why the excess mortality from psychiatric illness? Br Med J (Clin Res Ed). 1987;294:986-987.
73. Kales HC, Valenstein M, Kim HM, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry. 2007;164:1568-1576.
74. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150:1115-1121.
75. Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164:1293-1297.
76. Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75:234-241. (Pubitemid 38314873)
77. Drici MD, Priori S. Cardiovascular risks of atypical antipsychotic drug treatment. Pharmacoepidemiol Drug Saf. 2007;16:882-890.
78. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry. 2006;51:480-491.
79. Health Canada. Important drug safety information: RISPERDAL* (risperidone) and cerebrovascular adverse effects in placebo-controlled dementia trials-Janssen-Ortho Inc [Internet]. Ottawa (ON): Health Canada; 2002 [cited 2010 Apr 2]. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories- avis/prof/-2002/risperdal-hpc-cps-eng.php.
80. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-235.
81. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med. 2009;169:2128-2139.
82. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol. 2009;53:950-958.
83. O'Connor C, Fiuzat M. Antidepressant use, depression, and poor cardiovascular outcomes: the chicken or the egg?: Comment on "Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study." Arch Intern Med. 2009;169:2140-2141.
84. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285.
85. Kendrick T. Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Br J Psychiatry. 1996;169:733-739.
86. Brown S, Birtwistle J, Roe L, et al. The unhealthy lifestyle of people with schizophrenia. Psychol Med. 1999;29:697-701.
87. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606-2610.
88. Addington J, el-Guebaly N, Campbell W, et al. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry. 1998;155:974-976.
89. Hamer M, Stamatakis E, Steptoe A. Psychiatric hospital admissions, behavioral risk factors, and all-cause mortality: the Scottish health survey. Arch Intern Med. 2008;168:2474-2479.
90. Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry. 2009;194:491-499.
91. Kisely S, Smith M, Lawrence D, et al. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ. 2007;176:779-784.
92. Druss BG, Bradford DW, Rosenheck RA, et al. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000;283:506-511.
93. Laursen TM, Munk-Olsen T, Agerbo E, et al. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009;66:713-720.
94. Kisely S, Campbell LA, Wang Y. Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatry. 2009;195:545-550.
95. Kilbourne AM, Welsh D, McCarthy JF, et al. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. J Gen Intern Med. 2008;23:1628-1633.
96. Hippisley-Cox J, Parker C, Coupland C, et al. Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study. Heart. 2007;93:1256-1262.
97. Petersen LA, Normand SL, Druss BG, et al. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res. 2003;38:41-63.
98. Druss BG, Bradford WD, Rosenheck RA, et al. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001;58:565-572.
99. Shander D. Cardiovascular procedures in patients with mental disorders. JAMA. 2000;283:3198-3199.
100. Daumit GL, Pronovost PJ, Anthony CB, et al. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry. 2006;63:267-272.
101. Mallik S, Krumholz HM, Lin ZQ, et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation. 2005;111:271-277.
102. Phelan M, Stradins L, Morrison S. Physical health of people with severe mental illness. BMJ. 2001;322:443-444.
103. Smith S, Yeomans D, Bushe CJP, et al. A well-being programme in severe mental illness. Baseline findings in a UK cohort. Int J Clin Pract. 2007;61:1971-1978.
104. Kisely S, Campbell LA. Use of smoking cessation therapies in individuals with psychiatric illness: an update for prescribers. CNS Drugs. 2008;22:263-273. (Pubitemid 351367438)
105. Carney RM, Freedland KE. Depression in patients with coronary heart disease. Am J Med. 2008;121:S20-S27.
106. Joynt KE, O'Connor CM. Lessons from SADHART, ENRICHD, and other trials. Psychosom Med. 2005;67 Suppl 1:S63-S66.
107. Jordan N, Lee TA, Valenstein M, et al. Effect of depression care on outcomes in COPD patients with depression. Chest. 2009;135:626-632.